Author(s): Kalyani Lingamaneni, Mukthinuthalapati Mathrusri Annapurna

Email(s): kalyani.lingamaneni@gmail.com

DOI: 10.52711/0974-360X.2021.00369   

Address: Kalyani Lingamaneni*, Mukthinuthalapati Mathrusri Annapurna
Department of Pharmaceutical Analysis and Quality Assurance, Gandhi Institute of Technology and Management (Deemed to be University), GITAM Institute of Pharmacy, Visakhapatnam, Andhra pradesh-530045, India.
*Corresponding Author

Published In:   Volume - 14,      Issue - 4,     Year - 2021


ABSTRACT:
Telmisartan is an angiotensin receptor blocker and Hydrochlorothiazide is used to treat edema caused by various heart, kidney and liver diseases. Telmisartan is used in combination with a thiazide-type diuretic such as Hydrochlorothiazide by which an additive blood pressure lowering effect was proved. A new stability indicating liquid chromatographic method has been developed for the simultaneous estimation of Telmisartan and Hydrochlorthiazide in tablets. Chromatographic separation was achieved by using a X Bridge shield RP C-18 (150mm × 3.0mm, 3.5µm) column of Waters HPLC with Empower2 software and PDA detector, maintained at 45 ºC. Gradient mode of elution was performed and the flow rate of the mobile phase was 0.8 mL/min (Detector wavelength 235nm). Forced degradation studies were performed and the proposed method was found to be selective and specific.


Cite this article:
Kalyani Lingamaneni, Mukthinuthalapati Mathrusri Annapurna. Development and Validation of a New Stability Indicating Liquid Chromatographic Method for the Simultaneous quantification of Hydrochlorthiazide and Telmisartan. Research Journal of Pharmacy and Technology. 2021; 14(4):2081-8. doi: 10.52711/0974-360X.2021.00369

Cite(Electronic):
Kalyani Lingamaneni, Mukthinuthalapati Mathrusri Annapurna. Development and Validation of a New Stability Indicating Liquid Chromatographic Method for the Simultaneous quantification of Hydrochlorthiazide and Telmisartan. Research Journal of Pharmacy and Technology. 2021; 14(4):2081-8. doi: 10.52711/0974-360X.2021.00369   Available on: https://www.rjptonline.org/AbstractView.aspx?PID=2021-14-4-45


REFERENCES:
1. Laurence LB, John SL and Kaith LP. Goodman and Gilman’s The Pharmacological Basis of Therapeutics. McGraw-Hill. Eleventh Edition 2005. 
2. Wienen W, Entzeroth M, Meel JC, Stangier J, Busch U, Ebner T, et al. A review on Telmisartan: A novel, long acting angiotensin II-receptor antagonist. Cardiovasc Drug Rev. 2000; 18: 127-156. 
3. I.B. Lories, S.A. Samah, A.F. Laila, H.R. Heba. Application of first derivative, ratio derivative spectrophotometry, TLC densitometry, and spectrofluorimetry for the simultaneous determination of Telmisartan and Hydrochlorothiazide in pharmaceutical dosage forms and plasma. IL Farmaco, 2005; 60 (10): 859-867.
4. Shah NJ, Suhagia BN, Shah RR and Shah PB. Development and validation of a HPTLC method for the simultaneous estimation of Telmisartan and Hydrochlorothiazide in tablet dosage form. Indian Journal of Pharmaceutical Sciences. 2007; 69: 202-205. 
5. Yan T, Li H, Deng L, Guo Y, Yu W, Fawcett JP, et al. Liquid chromatographic-tandem mass spectrometric method for the simultaneous quantitation of Telmisartan and Hydrochlorothiazide in human plasma. J Pharm Biomed Anal. 2008; 48: 1225-1229.
6. Ismail Salama, Simultaneous HPLC-UV analysis of Telmisartan and Hydrochlorothiazide in human plasma. Bulletin of Faculty of Pharmacy, Cairo University. 2011: 49(1), 19-24.
7. Bhat LR, Godge RK, Vora AT, Damle MC. Validated RP-HPLC method for simultaneous determination of Telmisartan and Hydrochlorothiazide in pharmaceutical formulation. J Liq Chromatogr Relat Technol. 2007; 30 (17-20), 3059-3067.
8. Sutirtho M, Kiran K, Laxman S, Dhanashree N and Nancy P. Simultaneous determination of related substances of Telmisartan and Hydrochlorothiazide in tablet dosage form by using reversed phase high performance liquid chromatographic method. J Pharm Bioallied Sci. 2011; 3(3): 375-383. 
9. Megala K, Chenthilnathan A, Babu AS. Validated RP-HPLC method for simultaneous determination of Telmisartan and Hydrochlorothiazide in pharmaceutical formulation. Int. J. of Pharm. Res. & All. Sci. 2014; 3(3): 33-40.
10. Rane VP, Sangshetti JN, Shinde DB. Simultaneous high-performance liquid chromatographic determination of Telmisartan and Hydrochlorothiazide in pharmaceutical preparation. J Chromatogr Sci. 2008; 46(10), 887-891.
11. Wankhede SB, Tajne MR, Gupta KR and Wadodkar SG. RP-HPLC method for simultaneous estimation of Telmisartan and Hydrochlorothiazide in tablet dosage form. Indian J. Pharm. Sci. 2007; 69(2): 298-300.
12. Gopala Swamy T, Nagaraju K. and Lakshmana Rao A. RP-HPLC method for the simultaneous estimation of Telmisartan and Hydrochlorothiazide in Pharmaceutical Dosage Form, Int. J. Drug Dev. & Res., 2011; 3 (4): 362-368. 
13. ICH Validation of analytical procedures: Text and methodology, Q2 (R1), International Conference on Harmonization, 2005. 
14. Stability Testing of New Drug Substances and Products, ICH Harmonized Tripartite Guidelines, 1995. 

Recomonded Articles:

Research Journal of Pharmacy and Technology (RJPT) is an international, peer-reviewed, multidisciplinary journal.... Read more >>>

RNI: CHHENG00387/33/1/2008-TC                     
DOI: 10.5958/0974-360X 

1.3
2021CiteScore
 
56th percentile
Powered by  Scopus


SCImago Journal & Country Rank

Journal Policies & Information


Recent Articles




Tags


Not Available